We are live on
!
Find out more
BA
Bard Associates Portfolio holdings
AUM
$398M
1-Year Est. Return
54.32%
This Fund
S&P 500
This Quarter
Est. Return
+2.33%
1 Year Est. Return
+54.32%
3 Year Est. Return
+200.06%
5 Year Est. Return
+225.83%
10 Year Est. Return
+1,331.15%
AUM
$174M
AUM Growth
+$4.06M
(+2.4%)
Cap. Flow
+$7.47M
Cap. Flow
% of AUM
4.3%
Top 10 Holdings %
Top 10 Hldgs %
21.89%
Holding
169
New
9
Increased
30
Reduced
81
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
USA Compression Partners
USAC
|
+$2.2M |
| 2 |
HH
Hooper Holmes Inc
HH
|
+$1.17M |
| 3 |
GSB
GlobalSCAPE, Inc.
GSB
|
+$1.13M |
| 4 |
Targa Resources
TRGP
|
+$1.06M |
| 5 |
OCIP
OCI Partners LP
OCIP
|
+$785K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tyler Technologies
TYL
|
+$1.43M |
| 2 |
Jack Henry & Associates
JKHY
|
+$277K |
| 3 |
Icon
ICLR
|
+$273K |
| 4 |
VIA
Via Renewables, Inc. Class A Common Stock
VIA
|
+$219K |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$217K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 15.92% |
| 2 | Industrials | 13.73% |
| 3 | Technology | 12.63% |
| 4 | Materials | 10.79% |
| 5 | Healthcare | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Coherent
COHR
$50.9B
| $5.09M | 2.93% |
234,344
-3,000
| -1% | -$59.6K |
|
|
DHXM
2
DELISTED
DHX Media Ltd. Common Voting and Variable Voting Shares
DHXM
| $4.98M | 2.87% |
889,375
+14,350
| +2% | +$77.5K |
|
|
SRCL
3
DELISTED
Stericycle Inc
SRCL
| $4.44M | 2.56% |
35,220
-800
| -2% | -$93.2K |
|
4
US Physical Therapy
USPH
$1.2B
| $4.15M | 2.39% |
83,383
-605
| -0.7% | -$30.1K |
|
5
Carriage Services
CSV
$642M
| $3.84M | 2.21% |
177,552
-725
| -0.4% | -$15.5K |
|
|
6
Tyler Technologies
TYL
$12.7B
| $3.5M | 2.01% |
27,200
-10,275
| -27% | -$1.43M |
|
|
BCPC
7
Balchem Corp
BCPC
$5.27B
| $3.32M | 1.91% |
53,505
-950
| -2% | -$57K |
|
8
The Ensign Group
ENSG
$10.3B
| $3.07M | 1.77% |
145,053
+1,828
| +1% | +$36K |
|
|
9
USA Compression Partners
USAC
$3.85B
| $2.87M | 1.65% |
243,995
+224,170
| +1,131% | +$2.2M |
|
10
Invesco S&P SmallCap Utilities & Communication Services ETF
PSCU
$17.4M
| $2.77M | 1.59% |
61,490
-250
| -0.4% | -$10.6K |
|
|
SPA
11
DELISTED
Sparton
SPA
| $2.68M | 1.54% |
148,810
+1,860
| +1% | +$30.1K |
|
12
Team
TISI
$78.9M
| $2.63M | 1.52% |
8,664
+246
| +3% | +$63.1K |
|
13
Quaker Houghton
KWR
$2.82B
| $2.63M | 1.51% |
30,980
-450
| -1% | -$34.3K |
|
|
KMG
14
DELISTED
KMG Chemicals Inc
KMG
| $2.59M | 1.49% |
112,360
-400
| -0.4% | -$8.74K |
|
15
Acme United Corp
ACU
$216M
| $2.58M | 1.49% |
158,193
+2,725
| +2% | +$42.2K |
|
16
Willdan Group
WLDN
$1.08B
| $2.38M | 1.37% |
246,614
+12,445
| +5% | +$104K |
|
|
TGEN
17
Tecogen Inc
TGEN
$98.4M
| $2.25M | 1.29% |
574,950
+9,000
| +2% | +$34.2K |
|
|
HDSN
18
Hudson Technologies
HDSN
$249M
| $2.24M | 1.29% |
681,800
+62,900
| +10% | +$198K |
|
|
GPT
19
DELISTED
Gramercy Property Trust
GPT
| – | – |
0
| – | – |
|
|
RPT
20
Rithm Property Trust
RPT
$98.9M
| $2.2M | 1.27% |
33,966
-64
| -0.2% | -$4.02K |
|
21
Evolution Petroleum
EPM
$130M
| $2.19M | 1.26% |
449,725
-2,200
| -0.5% | -$9.89K |
|
22
NeoGenomics
NEO
$2.01B
| $2.15M | 1.24% |
319,423
-4,600
| -1% | -$30.3K |
|
|
SP
23
DELISTED
SP Plus Corporation
SP
| $2.11M | 1.21% |
87,580
-2,650
| -3% | -$61.2K |
|
|
RMT
24
Royce Micro-Cap Trust
RMT
$727M
| $2.07M | 1.19% |
295,746
+104,800
| +55% | +$695K |
|
25
NewtekOne
NEWT
$420M
| $1.98M | 1.14% |
158,349
+6,054
| +4% | +$69.2K |
|
Similar funds
FI
NC
T2I
THL
MHC
IAA
BWM
KHCM
Bard Associates's Q1 2016 Portfolio in Review
As of Q1 2016, Bard Associates held 169 positions worth $174M, up 2.4% from $170M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bard Associates deployed $7.47M of net new capital in Q1 2016, opening 9 new positions and adding to 30 existing holdings. Its largest new stake was Hooper Holmes Inc: 679,036 shares worth $1.42M.
By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Tyler Technologies, an estimated $1.43M trimmed.
- Bard Associates's largest Q1 2016 buy was Hooper Holmes Inc: 679,036 shares worth $1.42M.
- Bard Associates added most to USA Compression Partners in Q1 2016, an estimated $2.2M increase.
- Bard Associates's biggest Q1 2016 reduction was Tyler Technologies, cutting an estimated $1.43M.
- Bard Associates fully exited Teva Pharmaceuticals in Q1 2016, selling an estimated $217K.
- Bard Associates's ten largest holdings make up 22% of its $174M portfolio in Q1 2016.
- Bard Associates opened 9 new positions and closed 4 in Q1 2016.
- Bard Associates's portfolio value rose 2.4% quarter-over-quarter to $174M.
Based on Bard Associates's 13F filing for Q1 2016, filed 12 May 2016.